
John Carroll
@johncendpts
47 yrs before the mast. Invented FierceBiotech, founded Endpoints News w/ 230,000 subs. Devoting time to the big showdown with Merkel cell carcinoma . We'll see
ID: 102754598
http://endpts.com 07-01-2010 18:33:18
51,51K Tweet
69,69K Takipçi
103 Takip Edilen

When the Big Pharmas look to join a drug development race, they increasingly turn to China. This $1.25B $PFE deal marks a new stage in that trend. All this as the traditional supply chain from China is being ripped up for biotech. Kyle LaHucik has the story.

Anyone with any interest in biotech should read this Endpoints News survey and see what biotech CEOs are saying. Trump 2.0 is having a profound effect — and it’s unintentional. More collateral damage. endpts.com/endpoints-100-…






Day #304. Merkel cell carcinoma log. Completed my first visit Dana-Farber News with Dr. Ann Silk (colleagues call her Annie), now waiting for an infusion. Experienced, sharp Merkel cell carcinoma specialist who shed some light on treatment protocols, which will shift a bit now




Excited to be nominated by the ABSW with Sandra Kanthal for this incredible story about the fight for customised medicines and why we need to accelerate their development. Mila's Miracle Fyodor Urnov Genomics England Listen to the BBC Radio 4 doc & spread the word

Joining Drew Armstrong and Kyle LaHucik this afternoon at 3 pm et to discuss our recent Endpoints 100 biotech survey for Post-Hoc LIVE. It's clear the industry is at a crossroads right now, and the uncertainty about economic policy is playing hell with biotech. It wasn't supposed




